Advisors Asset Management’s Mural Oncology MURA Stock Holding History

Advisors Asset Management’s Portfolio MURA Stock Details MURA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-414	Closed	-$857	–	1479
2025 Q3	$857	Sell	414 -88	-18%	-$189	﹤0.01%	1438
2025 Q2	$1.24K	Sell	502 -7	-1%	-$16	﹤0.01%	1448
2025 Q1	$641	Sell	509 -1	-0.2%	-$4	﹤0.01%	1478
2024 Q4	$1.64K	Hold	510	–	–	﹤0.01%	1446
2024 Q3	$1.6K	Sell	510 -3	-0.6%	-$10	﹤0.01%	1437
2024 Q2	$1.61K	Sell	513 -2,463	-83%	-$9.08K	﹤0.01%	1436
2024 Q1	$14.6K	Buy	2,976 +478	+19%	+$2.32K	﹤0.01%	1376
2023 Q4	$14.8K	Buy	+2,498	New	+$10K	﹤0.01%	1371

Advisors Asset Management's MURA Position: Q4 2025 in Review

Advisors Asset Management sold out of Mural Oncology (MURA) in Q4 2025, closing a stake of 414 shares — an estimated $857 sold.

Advisors Asset Management first reported a position in MURA in Q4 2023 and held it in 8 quarters. The position peaked at $14.8K in Q4 2023. 0 funds tracked by Wall St. Rank hold MURA as of Q4 2025.

Advisors Asset Management reported no remaining Mural Oncology position as of Q4 2025 after selling out during the quarter.
Advisors Asset Management sold 414 Mural Oncology shares in Q4 2025, an estimated $857.
Advisors Asset Management first reported a position in Mural Oncology in Q4 2023 and held it in 8 quarters.
Advisors Asset Management's Mural Oncology position peaked at $14.8K in Q4 2023.
0 funds tracked by Wall St. Rank held Mural Oncology as of Q4 2025.

Based on Advisors Asset Management's 13F filing for Q4 2025, filed 12 Feb 2026.